281 related articles for article (PubMed ID: 33080602)
21. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
22. Role of liraglutide in Alzheimer's disease pathology.
Vargas-Soria M; Carranza-Naval MJ; Del Marco A; Garcia-Alloza M
Alzheimers Res Ther; 2021 Jun; 13(1):112. PubMed ID: 34118986
[TBL] [Abstract][Full Text] [Related]
23. Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus.
Pelle MC; Zaffina I; Giofrè F; Pujia R; Arturi F
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511061
[TBL] [Abstract][Full Text] [Related]
24. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
Klimova B; Kuca K; Maresova P
Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis.
Long C; Han X; Yang Y; Li T; Zhou Q; Chen Q
Front Aging Neurosci; 2022; 14():963933. PubMed ID: 36172480
[TBL] [Abstract][Full Text] [Related]
26. Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients With Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Basutkar RS; Sudarsan P; Robin SM; Bhaskar V; Viswanathan B; Sivasankaran P
Neurol India; 2023; 71(6):1132-1141. PubMed ID: 38174446
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
28. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
Pradhan SP; Sahu PK; Behera A
Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
[TBL] [Abstract][Full Text] [Related]
29. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.
Liu J; Wang LN; Jia JP
Drugs Aging; 2015 Jan; 32(1):57-65. PubMed ID: 25504005
[TBL] [Abstract][Full Text] [Related]
31. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
32. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment.
Poor SR; Ettcheto M; Cano A; Sanchez-Lopez E; Manzine PR; Olloquequi J; Camins A; Javan M
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577590
[TBL] [Abstract][Full Text] [Related]
33. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
[TBL] [Abstract][Full Text] [Related]
34. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
35. Auditory electrophysiological assessments of Alzheimer's disease and preclinical stages: protocol for a systematic review and meta-analysis.
Tarawneh HY; Mulders WHAM; Sohrabi HR; Martins RN; Jayakody DMP
BMJ Open; 2020 Jul; 10(7):e033308. PubMed ID: 32699123
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer's Disease.
Adem MA; Decourt B; Sabbagh MN
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255204
[TBL] [Abstract][Full Text] [Related]
37. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
Hird MA; Egeto P; Fischer CE; Naglie G; Schweizer TA
J Alzheimers Dis; 2016 May; 53(2):713-29. PubMed ID: 27176076
[TBL] [Abstract][Full Text] [Related]
38. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
Park SJ; Lee JE; Lee KS; Kim JS
Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
[TBL] [Abstract][Full Text] [Related]
39. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
Craig A; Parvez F; Issberner J
Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
[TBL] [Abstract][Full Text] [Related]
40. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].
García-Casares N; García-Arnés JA; Gómez-Huelgas R; Valdivielso-Felices P; García-Arias C; González-Santos P
Rev Neurol; 2014 Dec; 59(11):517-24. PubMed ID: 25418147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
